Eli Lilly plans to launch weight-loss drug in emerging markets this year
Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Global demand for Lilly's and Danish rival Novo Nordisk's diabetes and weight-loss drugs has been extraordinary, with the two ...
Who can get weight loss drugs on the NHS in Scotland?
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...
US FDA to hold off action on weight-loss drug copies pending court ruling
The health regulator announced last month that there was no longer a shortage of Novo's Wegovy and diabetes drug Ozempic, ...
The State of Weight Loss Drugs
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Revealed: Weight-loss jabs can TRIPLE risk of depression and suicide - as doctors unveil alarming new side effect
Over the past decade researchers have uncovered significant links between many of our most commonly used drugs - and patients ...
Devdiscourse15h
Eli Lilly's Global Expansion Plan for Blockbuster Drug Mounjaro
Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...
YourLifeChoices23h
How Ozempic and other GLP-1 agonist drugs turn down ‘food noise’ and cravings
When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but ...
Eli Lilly and Company (LLY) Management presents at Leerink 2025 Global Healthcare Conference (Transcript)
Leerink 2025 Global Healthcare Conference March 10, 2025 9:20 AM ETCompany ParticipantsLucas Montarce - CFOMike Czapar ...